Vaccines Market is Expected to Reach $57.8 Billion by 2019 - New Research Report by MarketsandMarkets
(PRWEB) February 26, 2015 -- The vaccines market is expected to reach $57,885.4 million by 2019 from $33,140.6 million in 2014, at a CAGR of 11.8%. The global vaccines market is categorized on the basis of type, technology, disease indication, end user and geography. The preventive vaccines segment is expected to register the highest growth rate in the vaccines market by type during the forecast period. Its favourable growth is attributed to the rising prevalence of diseases and increasing number of government initiatives taken for immunization programs worldwide.
Full Report Copy @ http://www.marketsandmarkets.com/Market-Reports/vaccine-technologies-market-1155.html
Major factors contributing to growth of the vaccines market include rising prevalence of diseases, increasing company investments in vaccine development and rising initiatives by non-government organizations for vaccinations. Furthermore government support in the form of funding is another major factor providing impetus for growth of this market. The emerging markets of the Asian region have opened an array of opportunities for the vaccines market. However low accessibility to vaccines in remote areas and stringent regulatory procedures are expected to restrain the growth of this market.
Ask for PDF @ http://www.marketsandmarkets.com/pdfdownload.asp?id=1155
Apart from the comprehensive geographical and product analysis and market sizing the report also provides a competitive landscape that covers the growth strategies adopted by the industry players over the last three years. In addition the company profiles comprise the basic views on the key players in the vaccines market and the product portfolios, developments and strategies adopted by the market players to maintain and increase their market shares in the near future. The above mentioned market research data, current market size and forecast of the future trends will help the key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in strategic approach, R&D investments for innovations in products and technologies and levels of output in order to remain successful.
About MarketsandMarkets
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Contact:
Mr. Rohan
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
e-mail: sales(at)marketsandmarkets(dot)com
Visit MarketsandMarkets Blog@ http://mnmblog.org/market-research/healthcare/biotechnology
Mr. Rohan, MarketsandMarkets, http://www.marketsandmarkets.com/, +91 9881155004, [email protected]
Share this article